Table 4 Cause of death and adverse events.

From: Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy

Death

N = 9

 GVHD

5

 Secondary neoplasm

1

 Relapse

1

 Infection

1

 Arythmia

1

Adverse events

N = 10

 Asthenia

2

 Nausea, vomiting

1

 Liver cytolysis

1

 Moderate to severe kidney failure

2

 Cholecystitis

1

 Myalgia

1

 Diarrhea

1

 Myocarditis

1

Back to article page